Eam Investors, LLC Harmony Biosciences Holdings, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $1.08 Million - $1.45 Million	23,738 New	23,738 $1.31 Million
Q2 2022 Aug 12, 2022	SELL	$33.54 - $52.15 $1.21 Million - $1.88 Million	-36,064 Reduced 62.9%	21,276 $1.04 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $1.9 Million - $2.93 Million	57,340 New	57,340 $2.79 Million

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.